TrialThe American journal of cardiology2014

Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).

Benjamin Wallace Van Tassell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.